Urginafect

Urginafect 5 mg or 10 mg Solifenacin Succinate 5 mg or 10 mg Film-coated tablets 1. Name of the medicinal product Urginafect 5 mg or 10 mg film-coated tablets 2. Qualitative and quantitative composition Each film-coated tablet contains 5 mg or 10 mg of Solifenacin Succinate. Excipient(s) with known effect: Each film-coated tablet of Urginafect 5 mg contains 81 mg lactose monohydrate. Urginafect 10 mg contains 76 mg lactose monohydrate. For the full list of excipients, see section 6.1. Therapeutic indications Urginafect is indicated in adults for symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder syndrome.